Oral squamous cell carcinoma (OSCC) affects a substantial proportion of the Asian population and is influenced by various genetic risk factors. The (), a regulator of the circadian rhythm, has been implicated in certain neoplasms. Accordingly, this study investigated the association between single-nucleotide polymorphisms and clinical manifestations of OSCC. A total of 1174 male patients without OSCC and 1254 male patients with OSCC were included in the study. Three single-nucleotide polymorphism loci-rs3750420 (T/C), rs10781247 (A/G), and rs17611535 (C/T)-were genotyped using TaqMan allelic discrimination assays. single-nucleotide polymorphism rs10781247 variants were significantly associated with moderate to poor cellular differentiation in patients with OSCC ( = 0.042). Additionally, among betel quid chewers with OSCC, rs10781247 variants were significantly associated with moderate to poor cell differentiation ( = 0.036). The rs3750420 variants were significantly associated with larger tumor size in individuals with buccal mucosa cancer ( = 0.036). An analysis of Cancer Genome Atlas data revealed that mRNA levels were significantly higher in patients with head and neck squamous cell carcinoma compared with controls ( = 0.0002). Moreover, mRNA levels were significantly higher in stage IV tumors than in stage III tumors ( = 0.0252). In conclusion, single-nucleotide polymorphisms rs3750420 and rs10781247 are associated with adverse clinical characteristics in OSCC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685680 | PMC |
http://dx.doi.org/10.7150/jca.103945 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!